What type of suppliers are considered brokers or intermediaries in pharmaceutical transactions?

In pharmaceutical transactions, brokers or intermediaries refer to parties that facilitate the connection between buyers and sellers of prescription drugs. These entities do not engage in the ownership of the drugs they deal with; instead, they act as a link, ensuring that the supply chain functions smoothly. Their role is crucial in the distribution of pharmaceuticals, as they help bridge the gap between manufacturers and pharmacies or healthcare providers, allowing for efficient transactions and broader access to medications.

This definition aligns with the characteristics of brokers, who typically engage in negotiations and make arrangements for the sale of drugs without taking possession of the products themselves. They may operate within regulatory frameworks that govern their actions to maintain compliance with laws related to drug distribution.

In contrast, large pharmaceutical companies engage in the manufacturing and often the wholesale distribution of drugs, while pharmacies that sell directly to consumers operate on a retail level and usually own the inventory they sell. Individuals who sell drugs without ownership could imply various roles but do not specifically denote the intermediary function in the same way brokers do. Therefore, the identification of parties connecting buyers and sellers accurately conveys the role of brokers in pharmaceutical transactions.